Canadian DIN & Molecule SearchMolecules A–ZDrug ShortagesResourcesHealth Canada WeeklyRequest a Quote

MINT-BETAHISTINE 24 MG

BETAHISTINE HYDROCHLORIDE : 24 MG · DIN 02538156 · MINT PHARMACEUTICALS INC

Health Canada status: MARKETED

What is MINT-BETAHISTINE?

MINT-BETAHISTINE 24 MG contains BETAHISTINE HYDROCHLORIDE : 24 MG. It is listed in the Health Canada Drug Product Database under DIN 02538156, held by MINT PHARMACEUTICALS INC, supplied as TABLET for ORAL administration. Health Canada currently lists it as marketed, status dated 31-Oct-2023. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.

What is MINT-BETAHISTINE used for?

MINT-BETAHISTINE (betahistine dihydrochloride) is indicated for: reducing the episodes of recurrent vertigo associated with Ménière’s disease.

Authorized indication as written in the Health Canada product monograph. For healthcare professionals and licensed purchasers; this is not medical advice.

Product details and regulatory record

DIN02538156
Brand nameMINT-BETAHISTINE
Generic / active ingredientBETAHISTINE HYDROCHLORIDE : 24 MG
ManufacturerMINT PHARMACEUTICALS INC
Strength24 MG
Dosage formTABLET
Route of administrationORAL
SchedulePrescription
ATC codeN07CA01 BETAHISTINE
BiosimilarNo
Health Canada statusMARKETED
Status date31-Oct-2023

How is it stored and handled?

Store tablets at controlled room temperature (15 to 30 °C).

How is it supplied?

8 mg tablets: Available in bottles of 30’s, 100’s and 500s. 16 mg tablets: Available in blisters of 100’s and bottles of 30’s, 100’s and 500s. 24 mg tablets: Available in blisters of 100’s and bottles of 30’s, 100’s and 500s.

What can be used instead?

Other Canadian products sharing ATC code N07CA01 BETAHISTINE. 17 of 33 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.

ProductStrengthFormManufacturerHealth Canada statusDIN
AURO-BETAHISTINE16 MGTABLETAURO PHARMA INCMARKETEDDIN 02449153
AURO-BETAHISTINE24 MGTABLETAURO PHARMA INCMARKETEDDIN 02449161
AURO-BETAHISTINE8 MGTABLETAURO PHARMA INCMARKETEDDIN 02449145
M-BETAHISTINE16 MGTABLETMANTRA PHARMA INCMARKETEDDIN 02519690
M-BETAHISTINE24 MGTABLETMANTRA PHARMA INCMARKETEDDIN 02519704
M-BETAHISTINE8 MGTABLETMANTRA PHARMA INCMARKETEDDIN 02519682
MINT-BETAHISTINE16 MGTABLETMINT PHARMACEUTICALS INCMARKETEDDIN 02538148
MINT-BETAHISTINE8 MGTABLETMINT PHARMACEUTICALS INCMARKETEDDIN 02538121
NRA-BETAHISTINE16 MGTABLETNORA PHARMA INCMARKETEDDIN 02544938
NRA-BETAHISTINE24 MGTABLETNORA PHARMA INCMARKETEDDIN 02544946

Who else supplies BETAHISTINE worldwide?

Nexara tracks national medicine registries and published price lists across multiple markets. BETAHISTINE appears in 113 registered pack listings across 8 markets, published on 6 different national price bases. Where a Canadian route is closed, that is where an alternative route of supply starts — subject to the import rules in both countries.

Registered listings are not stock. Ask us to confirm what can actually be sourced for your order.

How can I get it?

Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.

Request a quote for MINT-BETAHISTINE

Ordering questions

Who can buy this from Nexara?

Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.

Is there a minimum order?

Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.

What is the lead time?

Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.

Can Nexara supply this for a clinical trial?

Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.

Request a quote for MINT-BETAHISTINE

Health Canada Drug Product Database (DPD), DIN 02538156. Last reviewed 2026-09-08. Nexara Health is a licensed wholesaler and supplies licensed entities only; consumer orders are routed to a partner pharmacy.